GR81244B - Non-aqueous ivermectin formulation with improved antiparasitic activity - Google Patents

Non-aqueous ivermectin formulation with improved antiparasitic activity

Info

Publication number
GR81244B
GR81244B GR81244A GR840181244A GR81244B GR 81244 B GR81244 B GR 81244B GR 81244 A GR81244 A GR 81244A GR 840181244 A GR840181244 A GR 840181244A GR 81244 B GR81244 B GR 81244B
Authority
GR
Greece
Prior art keywords
aqueous
antiparasitic activity
ivermectin formulation
ivermectin
water
Prior art date
Application number
GR81244A
Other languages
English (en)
Inventor
Williams B James
Nesbitt V Russell
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of GR81244B publication Critical patent/GR81244B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GR81244A 1983-12-22 1984-12-12 Non-aqueous ivermectin formulation with improved antiparasitic activity GR81244B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56414083A 1983-12-22 1983-12-22

Publications (1)

Publication Number Publication Date
GR81244B true GR81244B (en) 1985-04-16

Family

ID=24253315

Family Applications (1)

Application Number Title Priority Date Filing Date
GR81244A GR81244B (en) 1983-12-22 1984-12-12 Non-aqueous ivermectin formulation with improved antiparasitic activity

Country Status (17)

Country Link
EP (1) EP0146414B1 (el)
JP (1) JPH0623100B2 (el)
KR (1) KR880002366B1 (el)
AT (1) ATE47522T1 (el)
AU (1) AU560864B2 (el)
CA (1) CA1267844A (el)
DE (1) DE3480263D1 (el)
DK (1) DK164772C (el)
ES (1) ES8608888A1 (el)
GR (1) GR81244B (el)
HK (1) HK5091A (el)
IE (1) IE57681B1 (el)
IL (1) IL73800A (el)
NZ (1) NZ210505A (el)
PT (1) PT79656B (el)
SG (1) SG97890G (el)
ZA (1) ZA849841B (el)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BG48572A3 (en) * 1987-01-23 1991-03-15 Pfizer Method for preparing of avermectines
US5075307A (en) * 1987-07-28 1991-12-24 Merck & Co., Inc. Paraherquamide and dihydroparaherquamide as antihelminthic agents
GB8803836D0 (en) * 1988-02-18 1988-03-16 Glaxo Group Ltd Compositions
US6001822A (en) * 1989-04-11 1999-12-14 Pfizer Inc. Antiparasitic formulations
US5169846A (en) * 1989-10-12 1992-12-08 Crooks Michael J Non-aqueous micellar solutions of anthelmintic benzimidazoles, closantel, or phenothiazine, and insect growth regulators
NZ335166A (en) 1999-04-14 2001-11-30 Ashmont Holdings Ltd Anthelmintic composition containing triclabendazole in at least one solvent
GB2275193A (en) * 1993-02-17 1994-08-24 Merck & Co Inc Formulations for the topical delivery of avermectins
RO115102B1 (ro) * 1993-05-10 1999-11-30 Merck & Co Inc Formulari topice pe baza de avermectina si procedee de preparare a acestora
US5602107A (en) * 1993-05-10 1997-02-11 Merck & Co., Inc. Pour-on formulations consisting of gylcols, glycerides and avermectin compounds
PL174488B1 (pl) * 1993-05-10 1998-08-31 Merck & Co Inc Preparat do zwalczania pasożytów zwierząt oraz sposób wytwarzania preparatu do zwalczania pasożytów zwierząt
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
DE19638045A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
US6054140A (en) * 1997-03-21 2000-04-25 Biogenesis S.A. Long acting injectable parasiticidal composition and the process for its preparation
UY25089A1 (es) * 1997-07-10 2000-08-21 Hoechst Roussel Vet Gmbh Vacunas no acuosas
GB9816132D0 (en) * 1998-07-24 1998-09-23 Norbrook Lab Ltd Non-aqueous anthelmintic composition
WO2001020994A1 (en) * 1999-09-22 2001-03-29 Ashmont Holdings Limited Sheep pour-on
JP2001253824A (ja) * 2000-03-14 2001-09-18 Mitsukazu Matsumoto 局所注射用処方剤
GR1003969B (el) * 2001-02-05 2002-08-14 U��-Pharma ����� ������ ������������ ���������� ���� Σταθερα φαρμακευτικα διαλυματα νιμεσουλιδης.
US20050009762A1 (en) 2003-06-06 2005-01-13 Strobel Michael Albert Application of water and organic solvent soluble ivermectin for topical and oral use
US6627613B2 (en) 2001-07-23 2003-09-30 Michael A. Strobel Application of water and organic solvent soluble ivermectin for topical and oral use
GB2386066A (en) 2002-02-28 2003-09-10 Norbrook Lab Ltd Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species
UY27412A1 (es) * 2002-08-12 2003-06-30 Carlson Internat Inc Un nuevo producto para el combate de garrapatas y el proceso para la prepaacinn.
GB0316377D0 (en) 2003-07-12 2003-08-13 Norbrook Lab Ltd Parasiticidal composition
JP4886214B2 (ja) * 2005-05-24 2012-02-29 日本パワーファスニング株式会社 石膏ボード締結用の２条式木ねじ
MX2011003720A (es) 2008-10-08 2011-04-28 Wyeth Llc Composiciones antihelminticas de bencimidazol.
JP5607114B2 (ja) 2012-06-26 2014-10-15 株式会社トープラ タッピンねじ
JP2024516912A (ja) 2021-05-14 2024-04-17 シンジェンタ クロップ プロテクション アクチェンゲゼルシャフト 昆虫、ダニ目及び線虫有害生物の防除
WO2022268815A1 (en) 2021-06-24 2022-12-29 Syngenta Crop Protection Ag Insect, acarina and nematode pest control

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144352A (en) * 1977-12-19 1979-03-13 Merck & Co., Inc. Milbemycin compounds as anthelmintic agents
US4130651A (en) * 1978-03-31 1978-12-19 American Cyanamid Company Butamisole injectable formulations having improved margin of safety in dogs
OA06863A (fr) * 1980-08-04 1983-02-28 Merck & Co Inc Solubilisation de l'invermectine dans l'eau.
US4430329A (en) * 1982-05-17 1984-02-07 Merck & Co., Inc. Synergistic treatment of adult canine heartworm with thiacetarsamide and ivermectin

Also Published As

Publication number Publication date
EP0146414A2 (en) 1985-06-26
SG97890G (en) 1991-02-14
DE3480263D1 (en) 1989-11-30
PT79656B (en) 1987-01-16
ES538750A0 (es) 1986-07-16
AU560864B2 (en) 1987-04-16
IL73800A0 (en) 1985-03-31
JPS60169415A (ja) 1985-09-02
ATE47522T1 (de) 1989-11-15
DK164772B (da) 1992-08-17
KR880002366B1 (ko) 1988-11-03
EP0146414A3 (en) 1986-12-10
JPH0623100B2 (ja) 1994-03-30
AU3702484A (en) 1985-07-04
CA1267844A (en) 1990-04-17
DK619784D0 (da) 1984-12-21
HK5091A (en) 1991-01-18
EP0146414B1 (en) 1989-10-25
NZ210505A (en) 1988-06-30
ES8608888A1 (es) 1986-07-16
ZA849841B (en) 1986-07-30
IE57681B1 (en) 1993-02-24
KR850004391A (ko) 1985-07-15
DK619784A (da) 1985-06-23
IE843221L (en) 1985-06-22
PT79656A (en) 1985-01-01
IL73800A (en) 1987-11-30
DK164772C (da) 1993-01-04

Similar Documents

Publication Publication Date Title
GR81244B (en) Non-aqueous ivermectin formulation with improved antiparasitic activity
IE811751L (en) Aqueous formulation
WO2001024763A3 (en) Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
CA2004598A1 (en) Medicinal aerosol formulations
AU549481B2 (en) Hair growing agent
ES547737A0 (es) Un dispositivo medico para la administracion transdermal de un agente biologicamente activo.
NO874869L (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
GR3005423T3 (el)
NO885598D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive ammoniumforbindelser.
NO171067C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4,5-dihydro- og 4,5,6,7-tetrahydro-pyrazolo (1,5-a)pyrimidiner
IT1178044B (it) Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridina
DE69528080T2 (de) Lösliche arzneizusammensetzungen enthaltend 2-chloro-2'-deoxyadenosine
ES284914Y (es) Dispositivo para la administracion percutanea de un principio activo.
EP0085501A3 (en) Improvements in pesticidal formulations
NO167573C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (5r, 6s,)-6-((r)-1-hydroksyetyl)-2-azacykloalkyltio-2-penem-3-karboksyl-syrederivater.
GR3002420T3 (en) Medicinal formulation
NO860091L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 12-amino-pyridazino(4[,5[:3,4)pyrrolo(2,1-a)isokinolin-derivater.
NO160142C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (1,2,4)triazolo(4,3-a)kinoksalin-4-amin-derivater.
NO166366C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cycloalkan (1,2-c:4,3-c')dipyrazoler.
AR241110A1 (es) Derivados de trihaloimidazol, composiciones insecticidas que los contienen como agente activo y metodo para producirlos.
NO165399C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (5r,6s)-6-((r)-1-hydroksyetyl)-penem-derivater.
Shah Preformulation and formulation of an oral dosage form of etoposide
GB2162746A (en) Antiacidotic medicinal agent
IT8223220A0 (it) Aril-alchil-piperazine farmaceuticamente attive, procedimenti per la loro preparazione e composizioni relative.
IT8024812A0 (it) Aril-alchil-piperazine farmaceuticamente attive, procedimenti per la loro preparazione e composizioni relative.